ES2530175T3 - Ensayos para la detección de autoanticuerpos contra fármacos anti-TNF - Google Patents
Ensayos para la detección de autoanticuerpos contra fármacos anti-TNF Download PDFInfo
- Publication number
- ES2530175T3 ES2530175T3 ES12707193.4T ES12707193T ES2530175T3 ES 2530175 T3 ES2530175 T3 ES 2530175T3 ES 12707193 T ES12707193 T ES 12707193T ES 2530175 T3 ES2530175 T3 ES 2530175T3
- Authority
- ES
- Spain
- Prior art keywords
- tnf
- sample
- labeled
- drug
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229940079593 drug Drugs 0.000 title abstract description 19
- 239000003814 drug Substances 0.000 title abstract description 19
- 238000001514 detection method Methods 0.000 title description 6
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 abstract description 24
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract description 24
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 abstract description 24
- 238000000034 method Methods 0.000 abstract description 13
- 239000002253 acid Substances 0.000 abstract description 4
- 238000001542 size-exclusion chromatography Methods 0.000 abstract description 4
- 230000003472 neutralizing effect Effects 0.000 abstract description 2
- 238000010494 dissociation reaction Methods 0.000 abstract 1
- 230000005593 dissociations Effects 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 10
- 238000002560 therapeutic procedure Methods 0.000 description 9
- 108700028353 OmpC Proteins 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 229920001184 polypeptide Polymers 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 150000001413 amino acids Chemical group 0.000 description 7
- 239000000427 antigen Substances 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 239000003550 marker Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 101000852992 Homo sapiens Interleukin-12 subunit beta Proteins 0.000 description 5
- 102100036701 Interleukin-12 subunit beta Human genes 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 229960000598 infliximab Drugs 0.000 description 5
- 229940116176 remicade Drugs 0.000 description 5
- 101001125026 Homo sapiens Nucleotide-binding oligomerization domain-containing protein 2 Proteins 0.000 description 4
- 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 4
- 101150111724 MEP1 gene Proteins 0.000 description 4
- 102100029441 Nucleotide-binding oligomerization domain-containing protein 2 Human genes 0.000 description 4
- 102100024333 Toll-like receptor 2 Human genes 0.000 description 4
- 230000009266 disease activity Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 102100031758 Extracellular matrix protein 1 Human genes 0.000 description 3
- 230000005526 G1 to G0 transition Effects 0.000 description 3
- 101000866526 Homo sapiens Extracellular matrix protein 1 Proteins 0.000 description 3
- 101001066435 Homo sapiens Hepatocyte growth factor-like protein Proteins 0.000 description 3
- 101000599940 Homo sapiens Interferon gamma Proteins 0.000 description 3
- 101000853000 Homo sapiens Interleukin-26 Proteins 0.000 description 3
- 101000578932 Homo sapiens Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 Proteins 0.000 description 3
- 101000586232 Homo sapiens ORM1-like protein 3 Proteins 0.000 description 3
- 101001117509 Homo sapiens Prostaglandin E2 receptor EP4 subtype Proteins 0.000 description 3
- 101000880431 Homo sapiens Serine/threonine-protein kinase 4 Proteins 0.000 description 3
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 3
- 101000597785 Homo sapiens Tumor necrosis factor receptor superfamily member 6B Proteins 0.000 description 3
- 102100037850 Interferon gamma Human genes 0.000 description 3
- 102100036679 Interleukin-26 Human genes 0.000 description 3
- 102100028328 Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 Human genes 0.000 description 3
- 102100030120 ORM1-like protein 3 Human genes 0.000 description 3
- 102100024450 Prostaglandin E2 receptor EP4 subtype Human genes 0.000 description 3
- 102100037629 Serine/threonine-protein kinase 4 Human genes 0.000 description 3
- 102100039360 Toll-like receptor 4 Human genes 0.000 description 3
- 102100024587 Tumor necrosis factor ligand superfamily member 15 Human genes 0.000 description 3
- 108090000138 Tumor necrosis factor ligand superfamily member 15 Proteins 0.000 description 3
- 102100035284 Tumor necrosis factor receptor superfamily member 6B Human genes 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 208000001234 inflammatory bowel disease 5 Diseases 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 2
- 102100032366 C-C motif chemokine 7 Human genes 0.000 description 2
- 241000193469 Clostridium pasteurianum Species 0.000 description 2
- 102100040324 E3 ubiquitin-protein ligase RNF186 Human genes 0.000 description 2
- 102220583772 Extracellular matrix protein 1_T130M_mutation Human genes 0.000 description 2
- 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 description 2
- 101001104289 Homo sapiens E3 ubiquitin-protein ligase RNF186 Proteins 0.000 description 2
- 101000893424 Homo sapiens Glucokinase regulatory protein Proteins 0.000 description 2
- 101001050473 Homo sapiens Intelectin-1 Proteins 0.000 description 2
- 101001019615 Homo sapiens Interleukin-18 receptor accessory protein Proteins 0.000 description 2
- 101000960946 Homo sapiens Interleukin-19 Proteins 0.000 description 2
- 101000853012 Homo sapiens Interleukin-23 receptor Proteins 0.000 description 2
- 101001005528 Homo sapiens LYR motif-containing protein 4 Proteins 0.000 description 2
- 101001059982 Homo sapiens Mitogen-activated protein kinase kinase kinase kinase 5 Proteins 0.000 description 2
- 101001133059 Homo sapiens Mucin-19 Proteins 0.000 description 2
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 2
- 102000026659 IL10 Human genes 0.000 description 2
- 102100023353 Intelectin-1 Human genes 0.000 description 2
- 108090000174 Interleukin-10 Proteins 0.000 description 2
- 102100035010 Interleukin-18 receptor accessory protein Human genes 0.000 description 2
- 102100039879 Interleukin-19 Human genes 0.000 description 2
- 102100036672 Interleukin-23 receptor Human genes 0.000 description 2
- 102100025154 LYR motif-containing protein 4 Human genes 0.000 description 2
- 108010020246 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Proteins 0.000 description 2
- 102100032693 Leucine-rich repeat serine/threonine-protein kinase 2 Human genes 0.000 description 2
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 2
- 102100028195 Mitogen-activated protein kinase kinase kinase kinase 5 Human genes 0.000 description 2
- 102100034257 Mucin-19 Human genes 0.000 description 2
- 108010013381 Porins Proteins 0.000 description 2
- 108091006766 SLC22A23 Proteins 0.000 description 2
- 102100023100 Solute carrier family 22 member 23 Human genes 0.000 description 2
- 238000012896 Statistical algorithm Methods 0.000 description 2
- 108010016200 Zinc Finger Protein GLI1 Proteins 0.000 description 2
- 102100035535 Zinc finger protein GLI1 Human genes 0.000 description 2
- 102220485438 Zinc finger protein GLI1_G933D_mutation Human genes 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 229960001743 golimumab Drugs 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000010647 peptide synthesis reaction Methods 0.000 description 2
- 102000007739 porin activity proteins Human genes 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 102210021745 rs10045431 Human genes 0.000 description 2
- 102210011296 rs11190140 Human genes 0.000 description 2
- 102200050485 rs11209026 Human genes 0.000 description 2
- 102210007410 rs11465804 Human genes 0.000 description 2
- 102200146742 rs2066844 Human genes 0.000 description 2
- 102200146596 rs2066845 Human genes 0.000 description 2
- 102200132076 rs2241880 Human genes 0.000 description 2
- 102210007414 rs4263839 Human genes 0.000 description 2
- 102200098764 rs4986790 Human genes 0.000 description 2
- 102200098513 rs4986791 Human genes 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- BQIMPGFMMOZASS-CLZZGJSISA-N (6r,7r)-7-amino-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(CO)=C(C(O)=O)N2C(=O)[C@@H](N)[C@H]21 BQIMPGFMMOZASS-CLZZGJSISA-N 0.000 description 1
- RBCCQATUVPNPGQ-UHFFFAOYSA-N 4-hexadecylaniline Chemical compound CCCCCCCCCCCCCCCCC1=CC=C(N)C=C1 RBCCQATUVPNPGQ-UHFFFAOYSA-N 0.000 description 1
- 102100021636 Actin-related protein 2/3 complex subunit 2 Human genes 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- 241000893512 Aquifex aeolicus Species 0.000 description 1
- 108010092776 Autophagy-Related Protein 5 Proteins 0.000 description 1
- 102000016614 Autophagy-Related Protein 5 Human genes 0.000 description 1
- 102100040355 Autophagy-related protein 16-1 Human genes 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102100025429 Butyrophilin-like protein 2 Human genes 0.000 description 1
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 1
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 1
- 102100036302 C-C chemokine receptor type 6 Human genes 0.000 description 1
- 102100025465 Calpain-10 Human genes 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 102100033187 Centrosomal protein of 72 kDa Human genes 0.000 description 1
- 101710202346 Centrosomal protein of 72 kDa Proteins 0.000 description 1
- 102100030099 Chloride anion exchanger Human genes 0.000 description 1
- 102100039193 Cullin-2 Human genes 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102100037799 DNA-binding protein Ikaros Human genes 0.000 description 1
- 101100457345 Danio rerio mapk14a gene Proteins 0.000 description 1
- 101100457347 Danio rerio mapk14b gene Proteins 0.000 description 1
- 102100022258 Disks large homolog 5 Human genes 0.000 description 1
- 102100023401 Dual specificity mitogen-activated protein kinase kinase 6 Human genes 0.000 description 1
- 102100039577 ETS translocation variant 5 Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010008165 Etanercept Proteins 0.000 description 1
- 108010040721 Flagellin Proteins 0.000 description 1
- 102100036242 HLA class II histocompatibility antigen, DQ alpha 2 chain Human genes 0.000 description 1
- 102100040485 HLA class II histocompatibility antigen, DRB1 beta chain Human genes 0.000 description 1
- 108010086786 HLA-DQA1 antigen Proteins 0.000 description 1
- 108010039343 HLA-DRB1 Chains Proteins 0.000 description 1
- 101000754220 Homo sapiens Actin-related protein 2/3 complex subunit 2 Proteins 0.000 description 1
- 101000964092 Homo sapiens Autophagy-related protein 16-1 Proteins 0.000 description 1
- 101000934738 Homo sapiens Butyrophilin-like protein 2 Proteins 0.000 description 1
- 101000716068 Homo sapiens C-C chemokine receptor type 6 Proteins 0.000 description 1
- 101000984149 Homo sapiens Calpain-10 Proteins 0.000 description 1
- 101000746072 Homo sapiens Cullin-2 Proteins 0.000 description 1
- 101000599038 Homo sapiens DNA-binding protein Ikaros Proteins 0.000 description 1
- 101000902114 Homo sapiens Disks large homolog 5 Proteins 0.000 description 1
- 101000624426 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 6 Proteins 0.000 description 1
- 101000813745 Homo sapiens ETS translocation variant 5 Proteins 0.000 description 1
- 101001003142 Homo sapiens Interleukin-12 receptor subunit beta-1 Proteins 0.000 description 1
- 101001003138 Homo sapiens Interleukin-12 receptor subunit beta-2 Proteins 0.000 description 1
- 101001010600 Homo sapiens Interleukin-12 subunit alpha Proteins 0.000 description 1
- 101000961065 Homo sapiens Interleukin-18 receptor 1 Proteins 0.000 description 1
- 101000971638 Homo sapiens Kinesin-like protein KIF1A Proteins 0.000 description 1
- 101001027634 Homo sapiens Kinesin-like protein KIF21B Proteins 0.000 description 1
- 101001008568 Homo sapiens Laminin subunit beta-1 Proteins 0.000 description 1
- 101000917826 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-a Proteins 0.000 description 1
- 101000950695 Homo sapiens Mitogen-activated protein kinase 8 Proteins 0.000 description 1
- 101001080401 Homo sapiens Proteasome assembly chaperone 1 Proteins 0.000 description 1
- 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 description 1
- 101000738413 Homo sapiens T-cell surface glycoprotein CD3 gamma chain Proteins 0.000 description 1
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 description 1
- 101000666295 Homo sapiens X-box-binding protein 1 Proteins 0.000 description 1
- 101000919269 Homo sapiens cAMP-responsive element modulator Proteins 0.000 description 1
- 101000747206 Homo sapiens tRNA pseudouridine synthase Pus10 Proteins 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 102100020790 Interleukin-12 receptor subunit beta-1 Human genes 0.000 description 1
- 102100020792 Interleukin-12 receptor subunit beta-2 Human genes 0.000 description 1
- 102100030698 Interleukin-12 subunit alpha Human genes 0.000 description 1
- 102000003810 Interleukin-18 Human genes 0.000 description 1
- 108090000171 Interleukin-18 Proteins 0.000 description 1
- 102100039340 Interleukin-18 receptor 1 Human genes 0.000 description 1
- 102100021527 Kinesin-like protein KIF1A Human genes 0.000 description 1
- 102100037690 Kinesin-like protein KIF21B Human genes 0.000 description 1
- 102100027448 Laminin subunit beta-1 Human genes 0.000 description 1
- 102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 description 1
- 108700012928 MAPK14 Proteins 0.000 description 1
- 101150003941 Mapk14 gene Proteins 0.000 description 1
- 102000054819 Mitogen-activated protein kinase 14 Human genes 0.000 description 1
- 102100037808 Mitogen-activated protein kinase 8 Human genes 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 101100454133 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) kstR2 gene Proteins 0.000 description 1
- 108091005461 Nucleic proteins Chemical group 0.000 description 1
- 101710203379 Outer membrane porin C Proteins 0.000 description 1
- 101710160101 Outer membrane protein C Proteins 0.000 description 1
- 102100027583 Proteasome assembly chaperone 1 Human genes 0.000 description 1
- 108091006504 SLC26A3 Proteins 0.000 description 1
- 102000005886 STAT4 Transcription Factor Human genes 0.000 description 1
- 108010019992 STAT4 Transcription Factor Proteins 0.000 description 1
- 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 description 1
- 102100037911 T-cell surface glycoprotein CD3 gamma chain Human genes 0.000 description 1
- 108010060818 Toll-Like Receptor 9 Proteins 0.000 description 1
- 102220642274 Toll-like receptor 4_S400N_mutation Human genes 0.000 description 1
- 102100033117 Toll-like receptor 9 Human genes 0.000 description 1
- 108010047933 Tumor Necrosis Factor alpha-Induced Protein 3 Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 102100024596 Tumor necrosis factor alpha-induced protein 3 Human genes 0.000 description 1
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 description 1
- 102100038151 X-box-binding protein 1 Human genes 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229960002964 adalimumab Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 102100029387 cAMP-responsive element modulator Human genes 0.000 description 1
- 229960003115 certolizumab pegol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940090100 cimzia Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229960000403 etanercept Drugs 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 102000057041 human TNF Human genes 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229960000856 protein c Drugs 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 102220090100 rs1045642 Human genes 0.000 description 1
- 102210007296 rs10883365 Human genes 0.000 description 1
- 102210008563 rs10889677 Human genes 0.000 description 1
- 102210007440 rs11805303 Human genes 0.000 description 1
- 102200012755 rs2032582 Human genes 0.000 description 1
- 102220001819 rs2066847 Human genes 0.000 description 1
- 102210011297 rs2201841 Human genes 0.000 description 1
- 102220147371 rs3212227 Human genes 0.000 description 1
- 102210007411 rs3828309 Human genes 0.000 description 1
- 102210033146 rs5743293 Human genes 0.000 description 1
- 102210021311 rs6478108 Human genes 0.000 description 1
- 102210011440 rs6478109 Human genes 0.000 description 1
- 102210009692 rs6556416 Human genes 0.000 description 1
- 102210021500 rs6584283 Human genes 0.000 description 1
- 102210007434 rs6887695 Human genes 0.000 description 1
- 102210019010 rs7517847 Human genes 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229940068638 simponi Drugs 0.000 description 1
- 238000003998 size exclusion chromatography high performance liquid chromatography Methods 0.000 description 1
- 238000012306 spectroscopic technique Methods 0.000 description 1
- 102100039155 tRNA pseudouridine synthase Pus10 Human genes 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 108091008023 transcriptional regulators Proteins 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161444097P | 2011-02-17 | 2011-02-17 | |
| US201161444097P | 2011-02-17 | ||
| US201161484594P | 2011-05-10 | 2011-05-10 | |
| US201161484594P | 2011-05-10 | ||
| US201161496501P | 2011-06-13 | 2011-06-13 | |
| US201161496501P | 2011-06-13 | ||
| PCT/US2012/025437 WO2012154253A1 (en) | 2011-02-17 | 2012-02-16 | ASSAYS FOR DETECTING AUTOANTIBODIES TO ANTI-TNFα DRUGS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2530175T3 true ES2530175T3 (es) | 2015-02-26 |
Family
ID=45809635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12707193.4T Active ES2530175T3 (es) | 2011-02-17 | 2012-02-16 | Ensayos para la detección de autoanticuerpos contra fármacos anti-TNF |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20140045276A1 (enExample) |
| EP (1) | EP2676137B1 (enExample) |
| JP (1) | JP6063398B2 (enExample) |
| KR (1) | KR20140008397A (enExample) |
| CN (1) | CN103502815B (enExample) |
| AU (1) | AU2012254150B2 (enExample) |
| BR (1) | BR112013020981A2 (enExample) |
| CA (1) | CA2827609A1 (enExample) |
| DK (1) | DK2676137T3 (enExample) |
| ES (1) | ES2530175T3 (enExample) |
| IL (1) | IL227853A (enExample) |
| MX (1) | MX343327B (enExample) |
| RU (1) | RU2013142278A (enExample) |
| SG (1) | SG192770A1 (enExample) |
| WO (1) | WO2012154253A1 (enExample) |
| ZA (1) | ZA201306950B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12281359B2 (en) | 2013-05-17 | 2025-04-22 | Cedars-Sinai Medical Center | Variants of TNFSF15 and DCR3 associated with Crohn's disease |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010062960A2 (en) | 2008-11-26 | 2010-06-03 | Cedars-Sinai Medical Center | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE |
| KR101881714B1 (ko) | 2009-10-26 | 2018-07-24 | 네스텍 소시에테아노님 | 항-ｔｎｆ 약물 및 자가항체의 검출을 위한 검정법 |
| JP5960707B2 (ja) | 2010-10-18 | 2016-08-02 | ネステク ソシエテ アノニム | 抗薬物抗体アイソタイプを決定するための方法 |
| EP3130921B1 (en) | 2011-07-06 | 2018-09-12 | Nestec S.A. | Assays for detecting neutralizing autoantibodies to biologic therapy with tnf alpha |
| CN104718453B (zh) | 2012-10-03 | 2017-03-08 | Gyros专利公司 | 酸性条件下分析物测定用方法和试剂盒 |
| ES2638971T3 (es) | 2012-10-05 | 2017-10-24 | Nestec S.A. | Métodos para predecir y monitorizar la cicatrización de la mucosa |
| BR112015012482A2 (pt) * | 2012-11-30 | 2017-07-11 | Nestec Sa | ensaios para detecção de autoanticorpos neutralizantes à terapia com produtos biológicos |
| EP2954329A1 (en) | 2013-02-05 | 2015-12-16 | Nestec S.A. | Methods of selecting combination therapy for colorectal cancer patients |
| DK3387898T3 (da) | 2013-03-15 | 2020-08-03 | Mayo Found Medical Education & Res | Identificering og monitorering af monoklonale immunglobuliner ved hjælp af molekylvægt |
| KR20230109779A (ko) | 2013-03-27 | 2023-07-20 | 세다르스-신나이 메디칼 센터 | Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한섬유증 및 염증의 완화 및 반전 |
| EP4105236A1 (en) | 2013-07-19 | 2022-12-21 | Cedars-Sinai Medical Center | Anti-tl1a (tnfsf15) antibody for treatment of inflammatory bowel disease |
| CA2932571A1 (en) | 2013-12-03 | 2015-06-11 | Nestec S.A. | Methods for predicting post-operative recurrence of crohn's disease |
| WO2015110989A1 (en) | 2014-01-23 | 2015-07-30 | Nestec S.A. | Biomarker panel for assessment of mucosal healing |
| MX374652B (es) | 2014-02-11 | 2025-03-06 | Genzyme Corp | Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco. |
| CA2944767C (en) | 2014-04-04 | 2022-07-12 | Mayo Foundation For Medical Education And Research | Isotyping immunoglobulins using accurate molecular mass |
| CN104034896A (zh) * | 2014-06-19 | 2014-09-10 | 华北制药集团新药研究开发有限责任公司 | 一种双抗体夹心elisa检测方法 |
| WO2016018978A1 (en) * | 2014-07-29 | 2016-02-04 | Mayo Foundation For Medical Education And Research | Quantifying monoclonal antibody therapeutics by lc-ms/ms |
| MX2017004742A (es) * | 2014-10-20 | 2017-07-20 | Nestec Sa | Métodos para la predicción de niveles de farmacos anti-tnf alfa y formación de autoanticuerpos. |
| BR112017004810A2 (pt) * | 2014-11-05 | 2017-12-12 | Hoffmann La Roche | imunoensaio |
| EP3536705A1 (en) | 2014-12-05 | 2019-09-11 | Société des Produits Nestlé S.A. | Isolated soluble alpha-4 integrin, beta-7 integrin and alpha-4/beta-7 heterodimer integrin |
| CN107110853A (zh) | 2015-01-09 | 2017-08-29 | 阿通诺米斯公司 | 确定TNFα抑制药及其相应抗药抗体的量的通用测定法 |
| WO2016135707A1 (en) | 2015-02-27 | 2016-09-01 | Nestec S.A. | Diagnosis of major depressive disorder, mild cognitive impairment, and alzheimer's disease and other neurologic and psychiatric disorders |
| EP3353200A4 (en) | 2015-09-24 | 2019-06-26 | Mayo Foundation for Medical Education and Research | IDENTIFICATION OF FREE LIGHT CHAINS FROM IMMOBILIZED LOBULIN BY MASS SPECTROMETRY |
| EP3165922B1 (en) * | 2015-11-06 | 2020-06-17 | Promise Proteomics | A method for quantifying therapeutic antibodies |
| KR20180127416A (ko) | 2016-03-17 | 2018-11-28 | 세다르스-신나이 메디칼 센터 | Rnaset2를 통한 염증성 장 질환의 진단 방법 |
| EP3482199A1 (en) | 2016-07-08 | 2019-05-15 | Atonomics A/S | A universal assay for determining the quantity of therapeutic monoclonal antibodies and their corresponding anti-drug-antibodies in samples |
| JP7060510B2 (ja) * | 2016-09-06 | 2022-04-26 | 富士レビオ株式会社 | 腫瘍マーカーの測定方法及び測定試薬 |
| EP3523647B1 (en) | 2016-09-07 | 2024-06-26 | Mayo Foundation for Medical Education and Research | Identification and monitoring of cleaved immunoglobulins by molecular mass |
| EP3681528B1 (en) | 2017-09-13 | 2025-07-23 | Mayo Foundation for Medical Education and Research | Identification and monitoring of apoptosis inhibitor of macrophage |
| EP3681907A4 (en) | 2017-09-13 | 2021-07-07 | Mayo Foundation for Medical Education and Research | IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN J-CHAINS |
| MX2020004921A (es) * | 2017-11-29 | 2020-08-27 | Hoffmann La Roche | Ensayo de anticuerpo antifarmaco con supresion de interferencia del objetivo. |
| US12385913B2 (en) * | 2018-08-03 | 2025-08-12 | Bristol-Myers Squibb Company | Methods for detecting anti-drug antibodies |
| CA3121162A1 (en) | 2018-11-29 | 2020-06-04 | Cedars-Sinai Medical Center | Rnaset2 compositions and methods of treatment therewith |
| KR20210126077A (ko) | 2019-02-11 | 2021-10-19 | 피닉스 몰레큘라 디자인스 | Rsk 억제제의 결정형 |
| JP2020115139A (ja) * | 2020-03-11 | 2020-07-30 | 国立大学法人千葉大学 | 血管炎の検査方法 |
| CN112362649B (zh) * | 2020-11-09 | 2024-07-12 | 长春金赛药业有限责任公司 | 一种rhGH中和抗体的检测方法 |
| KR102562006B1 (ko) | 2020-11-09 | 2023-08-02 | 바디텍메드(주) | 항tnf-알파 약물 모니터링을 위한 신속 검출 키트 |
| KR102568430B1 (ko) * | 2020-11-16 | 2023-08-24 | 바디텍메드(주) | 항 약물 항체의 신속 검출 방법 |
| CN114236139A (zh) * | 2021-12-30 | 2022-03-25 | 苏州和锐生物科技有限公司 | 一种TNF-α生物制剂的抗体检测试剂盒、制备方法 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4459359A (en) * | 1981-11-19 | 1984-07-10 | New York Blood Center, Inc. | Sensitive immunoassays of antigens or antibodies sequestered within immune complexes |
| FR2590674B1 (fr) * | 1985-11-25 | 1989-03-03 | Inst Nat Sante Rech Med | Nouveaux reactifs de diagnostic |
| DE3631229A1 (de) | 1986-09-13 | 1988-03-24 | Basf Ag | Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung |
| US5094740A (en) * | 1990-02-16 | 1992-03-10 | Glycomed, Inc. | Two-dimensional electrophoretic separation of carbohydrates |
| GB9028123D0 (en) * | 1990-12-28 | 1991-02-13 | Erba Carlo Spa | Monoclonal antibodies against human tumor necrosis factor alpha |
| US6033864A (en) | 1996-04-12 | 2000-03-07 | The Regents Of The University Of California | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens |
| US6074835A (en) | 1996-04-12 | 2000-06-13 | Regents Of The Univ. Of California | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone H1 |
| US6406862B1 (en) | 1998-10-06 | 2002-06-18 | The United States Of America As Represented By The Secretary Of The Army | Dip-stick assay for C-reactive protein |
| WO2000051637A1 (en) * | 1999-03-02 | 2000-09-08 | Centocor, Inc. | ANTI-TNFα ANTIBODIES IN THERAPY OF ASTHMA |
| US6309643B1 (en) | 1999-04-30 | 2001-10-30 | The Regents Of The University Of California | IBD-associated microbial antigens and methods of using same |
| FR2802536B1 (fr) | 1999-11-23 | 2003-06-13 | Chru Lille | Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections |
| FR2806739B1 (fr) | 2000-03-27 | 2005-02-18 | Fond Jean Dausset Ceph | Genes impliques dans les maladies inflammatoires de l'intestin et leur utilisation |
| US6838250B2 (en) | 2000-03-31 | 2005-01-04 | Ortho-Clinical Diagnostics, Inc. | Immunoassay for C-reactive protein |
| US7138237B1 (en) | 2000-05-19 | 2006-11-21 | Cedars-Sinai Medical Center | Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen |
| AU2002227350B2 (en) | 2000-10-30 | 2007-03-22 | Regents Of The University Of Michigan | Nod2 nucleic acids and proteins |
| EP1404712B1 (en) | 2000-10-30 | 2014-06-18 | The Regents Of The University Of Michigan | Nod2 nucleic acids and proteins |
| EP2071332A1 (en) | 2000-11-14 | 2009-06-17 | Techlab, Inc. | Method for monitoring persons with IBD using total endogeneous lactoferrin as a marker |
| EP1581119B1 (en) | 2001-12-17 | 2013-01-30 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
| US20040053263A1 (en) | 2002-08-30 | 2004-03-18 | Abreu Maria T. | Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease |
| ATE395596T1 (de) | 2002-10-25 | 2008-05-15 | Techlab Inc | Diagnostisches panel ibd-first chek fur entzundliche darmerkrankung (ibd) und reizkolon |
| US7662569B2 (en) | 2003-04-11 | 2010-02-16 | Cedars-Sinai Medical Center | Methods of assessing Crohn's disease patient phenotype by I2 serologic response |
| CA2549971A1 (en) | 2003-11-03 | 2005-05-12 | Duke University | Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke |
| WO2006004958A2 (en) * | 2004-06-30 | 2006-01-12 | Centocor, Inc. | Detection or measurement of antibodies to antigenic proteins in biological tissues or samples |
| WO2006012472A1 (en) | 2004-07-21 | 2006-02-02 | Qualyst, Inc. | Apparatus, kits and methods for evaluating binding interactions, for detecting and quantifying binding molecules, and for sample preparation |
| JP2007147367A (ja) * | 2005-11-25 | 2007-06-14 | Sekisui Chem Co Ltd | サイトカイン産生能の測定方法 |
| WO2008059515A2 (en) | 2006-08-01 | 2008-05-22 | Divyank Turakhia | A system and method of generating related words and word concepts |
| WO2008036802A2 (en) | 2006-09-21 | 2008-03-27 | Prometheus Laboratories Inc. | Antibody-based arrays for detecting multiple signal transducers in rare circulating cells |
| BRPI0813583A2 (pt) | 2007-07-13 | 2014-12-30 | Prometheus Lab Inc | Métodos para selecionar um medicamento anticâncer, para identificar a resposta de um tumor pulmonar, e para prognosticar a resposta de um paciente, e, arranjo |
| US20090035216A1 (en) * | 2007-08-03 | 2009-02-05 | Biomonitor Aps | Method for determining in vivo biopharmaceutical concentration or bioavailability |
| WO2009022001A1 (en) * | 2007-08-16 | 2009-02-19 | Novartis Ag | Improvement of drug tolerance in immunogenicity testing |
| WO2009091240A1 (en) * | 2008-01-15 | 2009-07-23 | Stichting Sanquin Bloedvoorziening | Method and kits for detecting antibodies against therapeutic antibodies |
| NZ600339A (en) | 2008-02-25 | 2013-12-20 | Nestec Sa | Drug selection for breast cancer therapy using antibody-based arrays |
| JP5634405B2 (ja) * | 2008-10-07 | 2014-12-03 | ユィロス・パテント・アクチボラグＧｙｒｏｓ Ｐａｔｅｎｔ ＡＢ | 試料中のアナライトの検出のための半逐次アッセイ |
| EP2430443B1 (en) | 2009-05-14 | 2018-06-27 | Pierian Holdings, Inc. | Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy |
| AU2010273319B2 (en) | 2009-07-15 | 2015-01-22 | Nestec S.A. | Drug selection for gastric cancer therapy using antibody-based arrays |
| US8408369B2 (en) | 2009-09-08 | 2013-04-02 | GM Global Technology Operations LLC | Bimetallic brake rotor |
| MX337666B (es) | 2009-10-20 | 2016-03-14 | Nestec Sa | Ensayos regulados mediante proximidad para detectar proteinas de fusion oncogenicas. |
| KR101881714B1 (ko) * | 2009-10-26 | 2018-07-24 | 네스텍 소시에테아노님 | 항-ｔｎｆ 약물 및 자가항체의 검출을 위한 검정법 |
-
2012
- 2012-02-16 ES ES12707193.4T patent/ES2530175T3/es active Active
- 2012-02-16 SG SG2013061692A patent/SG192770A1/en unknown
- 2012-02-16 BR BR112013020981A patent/BR112013020981A2/pt not_active Application Discontinuation
- 2012-02-16 WO PCT/US2012/025437 patent/WO2012154253A1/en not_active Ceased
- 2012-02-16 EP EP12707193.4A patent/EP2676137B1/en active Active
- 2012-02-16 AU AU2012254150A patent/AU2012254150B2/en not_active Ceased
- 2012-02-16 MX MX2013009570A patent/MX343327B/es active IP Right Grant
- 2012-02-16 CN CN201280018741.1A patent/CN103502815B/zh not_active Expired - Fee Related
- 2012-02-16 KR KR1020137024583A patent/KR20140008397A/ko not_active Ceased
- 2012-02-16 JP JP2013554602A patent/JP6063398B2/ja not_active Expired - Fee Related
- 2012-02-16 DK DK12707193.4T patent/DK2676137T3/en active
- 2012-02-16 CA CA2827609A patent/CA2827609A1/en not_active Abandoned
- 2012-02-16 RU RU2013142278/15A patent/RU2013142278A/ru not_active Application Discontinuation
-
2013
- 2013-08-07 US US13/961,841 patent/US20140045276A1/en not_active Abandoned
- 2013-09-03 IL IL227853A patent/IL227853A/en active IP Right Grant
- 2013-09-16 ZA ZA2013/06950A patent/ZA201306950B/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12281359B2 (en) | 2013-05-17 | 2025-04-22 | Cedars-Sinai Medical Center | Variants of TNFSF15 and DCR3 associated with Crohn's disease |
Also Published As
| Publication number | Publication date |
|---|---|
| DK2676137T3 (en) | 2015-01-19 |
| IL227853A (en) | 2017-07-31 |
| SG192770A1 (en) | 2013-09-30 |
| IL227853A0 (en) | 2013-09-30 |
| JP6063398B2 (ja) | 2017-01-18 |
| RU2013142278A (ru) | 2015-03-27 |
| EP2676137A1 (en) | 2013-12-25 |
| ZA201306950B (en) | 2015-04-29 |
| AU2012254150A1 (en) | 2013-05-02 |
| HK1191688A1 (en) | 2014-08-01 |
| BR112013020981A2 (pt) | 2016-10-11 |
| CN103502815B (zh) | 2015-09-23 |
| MX343327B (es) | 2016-11-01 |
| AU2012254150B2 (en) | 2015-08-13 |
| NZ614170A (en) | 2015-04-24 |
| JP2014508930A (ja) | 2014-04-10 |
| US20140045276A1 (en) | 2014-02-13 |
| CA2827609A1 (en) | 2012-11-15 |
| KR20140008397A (ko) | 2014-01-21 |
| WO2012154253A1 (en) | 2012-11-15 |
| CN103502815A (zh) | 2014-01-08 |
| EP2676137B1 (en) | 2014-12-31 |
| MX2013009570A (es) | 2013-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12485171B2 (en) | Methods of disease activity profiling for personalized therapy management | |
| DK2676137T3 (en) | TESTS TO DETECT AUTO ANTIBODIES FOR ANTI-TNF PHARMACEUTICALS | |
| Acharya et al. | PCR inhibition of a quantitative PCR for detection of Mycobacterium avium subspecies paratuberculosis DNA in feces: diagnostic implications and potential solutions | |
| CN103299190B (zh) | 确定抗药物抗体同种型的方法 | |
| AU2005314089B2 (en) | Methods for diagnosis and treatment of Crohn's disease | |
| MX2013015420A (es) | Ensayos para detectar auto anticuerpos neutralizadores de la terapia biologica con tnf alpha. | |
| AU2011202664B2 (en) | Methods for diagnosis and treatment of Crohn's disease | |
| WO2021178572A1 (en) | Non-invasive detection of salivary autoantibodies | |
| Mottram et al. | A systems biology approach identifies B cell maturation antigen (BCMA) as a biomarker reflecting oral vaccine induced IgA antibody responses in humans | |
| Miyaji et al. | Complement regulatory proteins (CD46, 55 and 59) expressed on Schwann cells: Immune targets in demyelinating neuropathies? | |
| RU2146368C1 (ru) | Способ выявления возбудителя инфекционного процесса в стерильных биологических средах макроорганизма | |
| Karakan | Gut Microbiota in Inflammatory Bowel Disease: Still More Questions Than Answers | |
| Fernández et al. | Antibody recognition of the hyper-glucosylated adhesin protein HMW1Ct of non-typeable Haemophilus influenzae in Rett syndrome | |
| Quraishi et al. | PTH-102 Association of gut microbiota with mucosal inflammation in ulcerative colitis | |
| van Slochteren et al. | P1406 Direct detection of bacterial DNA in clinical samples; evaluating a 4½ year period of sample collection and analysis | |
| NZ614170B2 (en) | Assays for detecting autoantibodies to anti-tnf? drugs | |
| HK1191688B (en) | ASSAYS FOR DETECTING AUTOANTIBODIES TO ANTI-TNFα DRUGS |